News | September 09, 2013

Loma Linda University Medical Center Explores New Frontiers in Proton Therapy

Nation’s First Hospital-Based Proton Therapy Center Takes Lead in Developing More Precise Proton Scanning Beam

September 9, 2013 — More than two decades after becoming the world’s first hospital-based proton therapy center, the engineers, scientists and physicians at Loma Linda University Medical Center (LLUMC) continue to develop new technologies that will lead to the next generation of proton therapy treatment.

Because of its pinpoint accuracy, proton therapy today is a highly effective form of treatment for two main reasons: one, there is significantly less radiation to surrounding healthy tissues; and two, it has the ability to take care of many types of tumors found in adults and children often considered difficult to treat with standard radiation therapies.

“One might think that all proton beams are created equal, but that’s not the case,” said Jerry D. Slater, M.D., chairman of the LLUMC Proton Treatment & Research Center. “Scatter beam technology was the first type of technology we developed, and we still consider it the most effective proton therapy beam available for many types of tumors. But as far back as 1985, we were looking at active beam scanning (ABS) technology for use at LLUMC to provide another tool for oncologists to use to maximize treatment benefits.”

As a leader in proton beam development, LLUMC’s research is committed to creating the most effective proton delivery methods. As such, LLUMC has spent considerable time and resources studying the potential of ABS technology and has developed a scanning-beam delivery system with superior resolution and spot size. LLUMC’s ABS technology provides our physicians with a tool to irradiate complex tumors with superior conformity and without the need for an aperture. When the technology is approved for use at LLUMC, the proton treatment center will be able to offer the patient a completely personalized treatment using either ABS or scatter beam technology combined with the experience that comes from being the first hospital-based proton center.

“Our research is showing the promise of ABS technology specifically for certain large and irregularly shaped tumor sites. But for certain smaller-scale targets, the scatter beam could still be the most effective treatment option for patients,” Slater said. As a consequence, doctors anticipate that the scatter beam will be utilized to deliver the necessary radiation approximately 70-85 percent of the time.

“As we have done throughout our history, we will continue to search for new frontiers in proton therapy and through clinical research bring the best of what we’ve learned to our patients in a safe and efficient way,” said Slater.

For more information, visit: www.lomalindahealth.org

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...
Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
Feature | Proton Therapy | October 04, 2018 | By Adam Conner-Simons
Investigating inside the human body often requires cutting open a patient or swallowing long tubes with built-in...